Galderma to Pursue a New Scientific Partnership with L’Oréal to Further Advance Its Category Leadership in Dermatology

Galderma announced that it has signed a memorandum of understanding [...]

By |2026-03-31T11:34:11-05:00August 6, 2024|Clinical Practice, Industry News, News|Comments Off on Galderma to Pursue a New Scientific Partnership with L’Oréal to Further Advance Its Category Leadership in Dermatology

Crown Laboratories Announces Acquisition of Select Assets from Healeon LLC, A Subsidiary of Bimini Health Tech

Crown Aesthetics, a Crown Laboratories, Inc. company and global innovative [...]

By |2026-03-31T11:34:17-05:00August 2, 2024|Industry News, Patient Care|Comments Off on Crown Laboratories Announces Acquisition of Select Assets from Healeon LLC, A Subsidiary of Bimini Health Tech

Alpha Aesthetics Partners Announces Significant Growth and New State Expansions

Alpha Aesthetics Partners, a Thurston Group portfolio company, announced it [...]

By |2026-03-31T11:34:18-05:00August 1, 2024|Industry News, Patient Care, Practice Management|Comments Off on Alpha Aesthetics Partners Announces Significant Growth and New State Expansions

Think Twice Before That Facelift: Hollywood’s Elite Are Turning to Dr. Simon Ourian’s Groundbreaking Stemcell Stimulator to Reverse Aging

Nestled in the opulent Beverly Hills, Dr. Simon Ourian’s Epione [...]

By |2026-03-31T11:34:19-05:00July 31, 2024|Industry News, Patient Care, Spotlights|Comments Off on Think Twice Before That Facelift: Hollywood’s Elite Are Turning to Dr. Simon Ourian’s Groundbreaking Stemcell Stimulator to Reverse Aging

Aesthetic Conversion Joins AmSpa as Silver Vendor Affiliate, Offers Deal for Members

Aesthetic Conversion has joined the American Med Spa Association (AmSpa) [...]

By |2026-03-31T15:50:16-05:00July 30, 2024|AmSpa News, Spotlights|Comments Off on Aesthetic Conversion Joins AmSpa as Silver Vendor Affiliate, Offers Deal for Members

Merz Aesthetics Announces FDA Approval of Xeomin (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced [...]

By |2026-03-31T11:34:24-05:00July 26, 2024|Clinical Practice, Industry News, Patient Care|Comments Off on Merz Aesthetics Announces FDA Approval of Xeomin (incobotulinumtoxinA) as the First and Only U.S. Neurotoxin for the Simultaneous Treatment of Upper Facial Lines
Go to Top